Targeting miR-21 to Treat Psoriasis-Reference-Cited by-同舟云学术

Targeting miR-21 to Treat Psoriasis

Published:2014-02-26 Issue:225 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Guinea-Viniegra Juan¹,Jiménez María¹,Schonthaler Helia B.¹,Navarro Raquel²,Delgado Yolanda²,José Concha-Garzón María²,Tschachler Erwin³,Obad Susanna⁴,Daudén Esteban²,Wagner Erwin F.¹

Affiliation:

1. F-BBVA–CNIO Cancer Cell Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.

2. Dermatology Department, Hospital La Princesa, Madrid 28006, Spain.

3. Dermatology Department, Medical University of Vienna, Vienna 1090, Austria.

4. Santaris Pharma, Hørsholm 2970, Denmark.

Abstract

Targeting miR-21 may be a new way to treat psoriasis.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference33 articles.

1. Pathogenesis and therapy of psoriasis

2. Molecular Dissection of Psoriasis: Integrating Genetics and Biology

3. Current and Emerging Systemic Treatment Strategies for Psoriasis

4. Psoriasis

5. Psoriasis: what we have learned from mouse models

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising strategies in natural products treatments of psoriasis-update;Frontiers in Medicine;2024-09-04

2. MicroRNA-718 inhibits mitochondrial fusion and ameliorates IMQ-induced psoriasis inflammation mediated by PHB and STAT1;2024-07-01

3. Research Progress on Micro (Nano)Plastics Exposure-Induced miRNA-Mediated Biotoxicity;Toxics;2024-06-29

4. Identification of an exosomal miRNA-mRNA regulatory network contributing to methotrexate efficacy;International Immunopharmacology;2024-06

5. The new era of immune skin diseases: Exploring advances in basic research and clinical translations;Journal of Translational Autoimmunity;2024-06